TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Marinus ( (MRNS) ).
Marinus Pharmaceuticals has announced a Senior Management Retention Plan and an Amended and Restated Change in Control Severance Plan. These plans aim to retain senior management during strategic transactions and provide severance payments in case of employment termination following a change in control.
More about Marinus
Marinus Pharmaceuticals, Inc. is a company in the pharmaceutical industry focused on developing innovative treatments. They are exploring strategic alternatives to maximize shareholder value.
YTD Price Performance: -97.88%
Average Trading Volume: 2,694,852
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $12.69M
For an in-depth examination of MRNS stock, go to TipRanks’ Stock Analysis page.